<?xml version="1.0" encoding="UTF-8"?>
<ref id="B81">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Grupp</surname>
    <given-names>S. A.</given-names>
   </name>
   <name>
    <surname>Kalos</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Barrett</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Aplenc</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Porter</surname>
    <given-names>D. L.</given-names>
   </name>
   <name>
    <surname>Rheingold</surname>
    <given-names>S. R.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2013</year>). 
  <article-title>Chimeric antigen receptor–modified T cells for acute lymphoid leukemia.</article-title>
  <source>
   <italic>N. Engl. J. Med.</italic>
  </source>
  <volume>368</volume>
  <fpage>1509</fpage>–
  <lpage>1518</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1215134</pub-id>
  <?supplied-pmid 23527958?>
  <pub-id pub-id-type="pmid">23527958</pub-id>
 </mixed-citation>
</ref>
